Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Men Who Have Sex with Men (MSM): A Scoping Review on PrEP Service Delivery and Programming

Alyson Hillis, Jennifer Germain, Vivian Hope, James McVeigh, Marie Claire Van Hout, Alyson Hillis, Jennifer Germain, Vivian Hope, James McVeigh, Marie Claire Van Hout

Abstract

Pre-exposure prophylaxis (PrEP) is an evidence-based new biomedical HIV prevention intervention, which involves the pre-emptive use of daily (or event-based) antiretroviral drugs, to reduce risk of HIV acquisition if exposed. PrEP has recently been positioned as an integral prevention tool to reduce HIV acquisition risk among men who have sex with men (MSM) at country-level and within global prevention strategies. Given this global scale up of PrEP, we conducted a scoping review of extant international literature documenting service related perspectives, models and lessons learnt in PrEP programming for MSM. A systematic search of literature was conducted, and restricted to English language records in the timeframe 2008 to February 2019. Eligibility criteria centered on whether studies broadly described PrEP programming and service delivery for MSM as well as health communication. Following exclusion of ineligible records and removal of duplicates, 84 records were charted and thematically analysed according to scoping review methods. Four themes emerged from the thematic analysis of data; 'PrEP service aspects, settings and staff'; 'PrEP prescriber experiences, therapeutic alliance and care planning'; 'PrEP adherence within formal service structures'; and 'Multi-disciplinary and innovative PrEP care pathways'. The review highlights the complexities in providing optimal PrEP services for MSM by mapping and illustrating the importance of understanding the informal and formal routes to PrEP use among this HIV risk population; the barriers to uptake; the requirement for the presence of a positive therapeutic alliance between patient and prescriber in supporting patient initiation and adherence to PrEP regimes; and the need for availability in different culturally and ethnically sensitive models of PrEP service delivery according to low to high risk groups within the MSM communities.

Keywords: Biomedical prevention products; HIV prevention; MSM; Men who have sex with men; PrEP; Pre-exposure prophylaxis.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flowchart for inclusion and exclusion of literature
Fig. 2
Fig. 2
PrEP service delivery model

References

    1. UNAIDS. Prevention Gap Report. 2016c. . Accessed Jan 2019.
    1. UNAIDS. Strategy on the Fast Track to end AIDS 2016–2021. 2016d. Accessed Jan 2019.
    1. UNAIDS. 90–90–90: An ambitious treatment target to help end the AIDS epidemic. 2019. . Accessed June 2019.
    1. AIDSMAP. The UK is moving towards elimination of HIV transmission. 2017. . Accessed July 2019.
    1. UNAIDS. Global AIDS update. 2016a; Available at: . Accessed June 2019.
    1. CDC. HIV among gay and bisexual men. 2015. . Accessed Jan 2019.
    1. Chris B, Andrea LW, Damian W et al. The global HIV epidemics in men who have sex with men. The International Bank for Reconstruction and Development. 2011.
    1. Peng P, Su S, Fiarley C, et al. Global estimate of the acceptability of pre-exposure prophylaxis for HIV among men who have sex with men: a systematic review and meta-analysis. AIDS Behav. 2018;22:1063–1074.
    1. NCAIDS, NCSTD, China CCD. Update on the AIDS/STD epidemic in China and main response in control and prevention in December, 2015. China J AIDS STD. 2016;22(2):69. . Accessed Jan 2019.
    1. UNAIDS. The Gap Report 2014. 2014. . Accessed June 2019.
    1. UNFPA. Implementing comprehensive HIV and STI programmes with men who have sex with men: practical guidance for collaborative interventions. 2015. . Accessed Aug 2019.
    1. Freeborn K, Portillo CJ. Does preexposure prophylaxis for HIV prevention in men who have sex with men change risk behaviour? A systematic review. J Clin Nurs. 2018;27:3254–3265.
    1. Stover J, Bollinger L, Izazola JA, et al. What is required to end the AIDS epidemic as a public health threat by 2030? The cost and impact of the fast-track approach. PLoS ONE. 2016;11(5):20154893.
    1. Davies O. Pre-exposure prophylaxis for hiv prevention: why, what who and how. Infect Dis Ther. 2016;5:406–416.
    1. WHO. Guidance on pre-exposure oral prophylaxis (PrEP) for serodiscordant couples, men and transgender womenwho have sex with men at high risk of HIV: Recommendations for use in the context of demonstration projects. 2012. . Accessed June 2019.
    1. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–2599.
    1. Liu A, Cohen S, Vittinghoff E. Adherence, sexual behavior and HIV/STI incidence among men who have sex with men (MSM) and transgender women (TGW) in the US PrEP demonstration (Demo) project. In: 8th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention. Vancouver, 2015.
    1. Molina JM, Capitant C, Spire B, et al. On-demand preexposure prophylaxis in menat high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237–2246.
    1. McCormack S. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387:53–60.
    1. Trager M, Schroeder S, Wright E, et al. Effects of pre-exposure prophylaxis for the prevention of human immunodeficiency virus infection on sexual risk behavior in men who have sex with men: a systematic review and meta-analysis. Clin Infect Dis. 2018;67(5):676–686.
    1. Anderson PL, Glidden DV, Liu A. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4:1–8.
    1. Baeten JM, Grant R. Use of antiretrovirals for HIV prevention: what do we know and what don't we know? Curr HIV/AIDS Rep. 2013;10:142–151.
    1. Charania MR, Crepaz N, Guenther-Gray C, et al. Efficacy of structural-level condom distribution interventions: a meta-analysis of U.S. and international studies 1998–2007. AIDS Behav. 2011;15(7):1283–1297.
    1. Ford N, Irvine C, Shubber Z, et al. Adherence to HIV postexposure prophylaxis: a systematic review and meta-analysis. AIDS. 2014;28(18):2721–2727.
    1. Nugroho A, Erasmus V, Zomer TP, Wu Q, Richardus JH. Behavioral interventions to reduce HIV risk behavior for MSM and transwomen in Southeast Asia: a systematic review. AIDS Care. 2017;29(1):98–104.
    1. Templeton DJ, Millett GA, Grulich AE. Male circumcision to reduce the risk of HIV and sexually transmitted infections among men who have sex with men. Curr Opin Infect Dis. 2010;23(1):45–52.
    1. WHO. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. 2015. . Accessed June 2019.
    1. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach, second edition. 2016. . Accessed Jan 2019.
    1. WHO. PrEP demonstration projects: a framework for country level protocol development. 2013. . Accessed June 2019.
    1. Ding Y, Yan H, Ning Z, et al. Low willingness and actual uptake of pre-exposure prophylaxis for HIV-1 prevention among men who have sex with men in Shanghai. China Biosci Trends. 2016;10(2):113–119.
    1. Holt M. HIV pre-exposure prophylaxis and treatment as prevention: a review of awareness and acceptability among men who have sex with men in the Asia-Pacific region and the Americas. Sex Health. 2014;11:166–170.
    1. Kirby T, Thornber-Dunwell M. Uptake of PrEP for HIV slow among MSM. Lancet. 2014;383:399–400.
    1. Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: a review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18:195–216.
    1. Underhill K, Morrow KM, Colleran C, et al. A qualitative study of medical mistrust, perceived discrimination, and risk behavior disclosure to clinicians by U.S. male sex workers and other men who have sex with men: implications for biomedical HIV prevention. J Urban Health. 2015;92(4):667–686.
    1. Amico KR, Stirratt MJ. Adherence to preexposure prophylaxis: current, emerging, and anticipated bases of evidence. Clin Infect Dis. 2014;59(Supplement 1):S55–60.
    1. Zhou F, Gao L, Li S, et al. Willingness to accept HIV pre-exposure prophylaxis among Chinese men who have sex with men. PLoS ONE. 2012;7(3):e32329.
    1. Blumenthal J, Haubrich R. Risk compensation in PrEP: an old debate emerges yet again. Virtual Mentor. 2014;16:909–915.
    1. Marcus JL, Glidden DV, Mayer KH, et al. No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. PLoS ONE. 2013;8(12):e81997.
    1. Fonner VA, Dalglish SL, Kennedy CE. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30:1973–1983.
    1. Mugwanya KK, Baeten JM. Safety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention. Expert Opin Drug Saf. 2016;15(2):265–273.
    1. Eaton L, Driffin D, Smith H, et al. Psychosocial factors related to willingness to use pre-exposure prophylaxis for HIV prevention among Black men who have sex with men attending a community event. Sex Health. 2014;11(3):244–251.
    1. Grov C, Whitfield T, Rendina H, Ventuneac A, Parsons JT. Willingness to Take PrEP and potential for risk compensation among highly sexually active gay and bisexual men…pre-exposure prophylaxis. AIDS Behav. 2015;19(12):2234–2244.
    1. Holloway I, Tan D, Gildner J, et al. Facilitators and barriers to pre-exposure prophylaxis willingness among young men who have sex with men who use geosocial networking applications in California. AIDS Patient Care STDs. 2017;31(12):517–527.
    1. Klevens R, Martin B, Doherty R, et al. Factors associated with pre-exposure prophylaxis in a highly insured population of Urban men who have sex with men, 2014. AIDS Behav. 2018;22(4):1201–1208.
    1. Rimal RN, Lapinski MK. Why health communication is important in public health. Bull World Health Organ. 2009;87:247.
    1. Trust TH. Make PrEP available. 2019. . Accessed Oct 2019.
    1. Anderson S, Allen P, Peckham S, Goodwin N. Asking the right questions: scoping studies in the commissioning of research on the organisation and delivery of health services. Health Res Policy Syst. 2008;6(1):7.
    1. Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8:19–32.
    1. Daudt H, van Mossel C, Scott S. Enhancing the scoping study methodology: a large, inter-professional team’s experience with Arksey and O’Malley’s framework. BMC Med Res Methodol. 2013;13(1):48.
    1. Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5(1):69.
    1. Brouwers, P. Improving the HIV Pre-Exposure Prophylaxis (PrEP) Cascade. 2015. . Accessed Oct 2019.
    1. Anand T, Nitpolprasert C, Trachunthong D, et al. A novel online-to-offline (O2O) model for pre-exposure prophylaxis and HIV testing scale up. J Int AIDS Soc. 2017;20(1):21326–21326.
    1. Phanuphak N, Sungsing T, Jantarapakde J, et al. Princess PrEP program: the first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand. Sex Health. 2018;15(6):542–555.
    1. Tangmunkongvorakul A, Chariyalertsak S, Amico RK, et al. Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx Study in Chiang Mai Thailand. AIDS Care. 2013;25(8):961–967.
    1. Hoffman S, Guidry JA, Collier KL, et al. A clinical home for preexposure prophylaxis: diverse health care providers' perspectives on the "purview paradox". Int Assoc Provid AIDS Care. 2016;15(1):59–65.
    1. John SA, Rendina HJ, Grov C, Parsons JT. Home-based pre-exposure prophylaxis (PrEP) services for gay and bisexual men: an opportunity to address barriers to PrEP uptake and persistence. PLoS ONE. 2017;12(12):e0189794–e0189794.
    1. Krakower DS, Ware NC, Maloney KM, et al. Differing experiences with pre-exposure prophylaxis in boston among lesbian, gay, bisexual, and transgender specialists and generalists in primary care: implications for scale-up. AIDS Patient Care STDs. 2017;31(7):297–304.
    1. Mullins TLK, Zimet G, Lally M, et al. HIV care providers' intentions to prescribe and actual prescription of pre-exposure prophylaxis to at-risk adolescents and adults. AIDS Patient Care STDs. 2017;31(12):504–516.
    1. Ojile N, Sweet D, Kallail KJ. A preliminary study of the attitudes and barriers of family physicians to prescribing HIV preexposure prophylaxis. Kans J Med. 2017;10(2):40–42.
    1. Parsons JT, John SA, Whitfield THF, Cienfuegos-Szalay J, Grov C. HIV/STI counseling and testing services received by gay and bisexual men using pre-exposure prophylaxis (PrEP) at their last PrEP care visit. Sex Transm Dis. 2018;45(12):798–802.
    1. Patel RR, Chan PA, Harrison LC, et al. Missed opportunities to prescribe HIV pre-exposure prophylaxis by primary care providers in Saint Louis Missouri. LGBT Health. 2018;5(4):250–256.
    1. Sun C, Anderson K, Bangsberg D, et al. Access to HIV pre-exposure prophylaxis in practice settings: a qualitative study of sexual and gender minority adults’ perspectives. J Gen Intern Med. 2019;34:535–543.
    1. Tellalian D, Maznavi K, Bredeek UF, Hardy WD. Pre-exposure prophylaxis (PrEP) for HIV infection: results of a survey of HIV healthcare providers evaluating their knowledge, attitudes, and prescribing practices. AIDS Patient Care STDs. 2013;27(10):553–559.
    1. Bien C, Patel V, Blackstock O, Felsen U. Reaching key populations: PrEP Uptake in an Urban health care system in the Bronx New York. AIDS Behav. 2017;21(5):1309–1314.
    1. Arnold EA, Hazelton P, Lane T, et al. A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PLoS ONE. 2012;7(7):e40603–e40603.
    1. Desrosiers A, Levy M, Dright A, et al. A randomized controlled pilot study of a culturally-tailored counseling intervention to increase uptake of HIV pre-exposure prophylaxis among young black men who have sex with men in Washington DC. AIDS Behav. 2018;23:105–115.
    1. Doblecki-Lewis S, Jones D. Community federally qualified health centers as homes for HIV preexposure prophylaxis: perspectives from South Florida. J Int Assoc Provid AIDS Care. 2016;15(6):522–528.
    1. Calabrese SK, Magnus M, Mayer KH, et al. Putting PrEP into practice: lessons learned from early-adopting U.S. providers' firsthand experiences providing HIV pre-exposure prophylaxis and associated care. PLoS ONE. 2016;11(6):e0157324.
    1. Clement ME, Okeke NL, Munn T, et al. Partnerships between a university-affiliated clinic and community-based organizations to reach black men who have sex with men for PrEP care. J Acquir Immune Defic Syndr. 2018;77(2):e25–e27.
    1. Doblecki-Lewis S, Liu A, Feaster D, et al. Healthcare access and PrEP continuation in San Francisco and Miami after the US PrEP demo project. J Acquir Immune Defic Syndr. 2017;74(5):531–538.
    1. Ojikutu B, Bogart L, Mayer K, et al. Spatial access and willingness to use pre-exposure prophylaxis among black/African American individuals in the United States: Cross-Sectional Survey. JMIR Public Health Surveill. 2019;5(1):1–8.
    1. Paparini S, Nutland W, Rhodes T, Nguyen V, Anderson J. DIY HIV prevention: formative qualitative research with men who have sex with men who source PrEP outside of clinical trials. PLoS ONE. 2018;13(8):e0202830–e0202830.
    1. Parisi D, Warren B, Leung SJ, et al. A multicomponent approach to evaluating a pre-exposure prophylaxis (PrEP) implementation program in five agencies in New York. J Assoc Nurs AIDS Care. 2018;29(1):10–19.
    1. Adams LM, Balderson BH. HIV providers' likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report. AIDS Care. 2016;28(9):1154–1158.
    1. Adams LM, Balderson BH, Brown K, Bush SE, Packett BJ. Who starts the conversation and who receives preexposure prophylaxis (PrEP)? a brief online survey of medical providers’ PrEP practices. Health Educ Behav. 2018;45(5):723–729.
    1. Clement ME, Seidelman J, Wu J, et al. An educational initiative in response to identified PrEP prescribing needs among PCPs in the Southern U.S. AIDS Care. 2018;30(5):650–655.
    1. Grimm J, Schwartz J. "It's like birth control for HIV": communication and stigma for gay men on PrEP. J Homosex. 2018;66:1179–1197.
    1. Klassen BJ, Lin SY, Lachowsky NJ, et al. Gay men’s understanding and education of new HIV prevention technologies in vancouver Canada. Qual Health Res. 2017;27(12):1775–1791.
    1. Lelutiu-Weinberger C, Golub SA. Enhancing PrEP access for black and latino men who have sex with men. J Acquir Immune Defic Syndr. 2016;73(5):547–555.
    1. Maloney KM, Krakower DS, Ziobro D, et al. Culturally competent sexual healthcare as a prerequisite for obtaining preexposure prophylaxis: findings from a qualitative study. LGBT Health. 2017;4(4):310–314.
    1. Raifman JRG, Flynn C, German D. Healthcare provider contact and pre-exposure prophylaxis in baltimore men who have sex with men. Am J Prev Med. 2017;52(1):55–63.
    1. Hubach RD, Currin JM, Sanders CA, et al. Barriers to access and adoption of pre-exposure prophylaxis for the prevention of hiv among men who have sex with men (MSM) in a relatively rural state. AIDS Educ Prev. 2017;29(4):315–329.
    1. Beach LB, Greene GJ, Lindeman P, et al. Barriers and facilitators to seeking HIV services in Chicago among young men who have sex with men: perspectives of HIV service providers. AIDS Patient Care STDS. 2018;32(11):468–476.
    1. Aloysius I, Savage A, Zdravkov J, et al. (2017) InterPrEP. Internet-based pre-exposure prophylaxis with generic tenofovir DF/emtricitabine in London: an analysis of outcomes in 641 patients. J Virus Erad. 2017;3(4):218–222.
    1. Eaton LA, Matthews DD, Bukowski LA, et al. Elevated HIV prevalence and correlates of PrEP use among a community sample of black men who have sex with men. J Acquir Immune Defic Syndr. 2018;79:339–346.
    1. Levy ME, Watson CC, Glick SN, et al. Receipt of HIV prevention interventions is more common in community-based clinics than in primary care or acute care settings for Black men who have sex with men in the District of Columbia. AIDS Care. 2016;28(5):660–664.
    1. Mayer K, Safren S, Elsesser S, et al. Optimizing pre-exposure antiretroviral prophylaxis adherence in men who have sex with men: results of a pilot randomized controlled trial of 'life-steps for PrEP'. AIDS Behav. 2017;21(5):1350–1360.
    1. Elst E, Mbogua J, Operario D, et al. High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS Behav. 2013;17(6):2162–2172.
    1. Fuchs JD, Stojanovski K, Vittinghoff E, et al. A mobile health strategy to support adherence to antiretroviral preexposure prophylaxis. AIDS Patient Care STDS. 2018;32(3):104–111.
    1. Landovitz RJ, Beymer M, Kofron R, et al. Plasma tenofovir levels to support adherence to TDF/FTC preexposure prophylaxis for HIV prevention in MSM in Los Angeles California. J Acquir Immune Defic Syndr. 2017;76(5):501–511.
    1. Pasipanodya EC, Jain S, Sun X, et al. Trajectories and predictors of longitudinal preexposure prophylaxis adherence among men who have sex with men. J Infect Dis. 2018;218(10):1551–1559.
    1. Gilmore HJ, Liu A, Koester KA, et al. Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx pre-exposure prophylaxis trial in San Francisco. AIDS Patient Care STDs. 2013;27(10):560–566.
    1. Amico KR, McMahan V, Goicochea P, et al. Supporting study product use and accuracy in self-report in the iPrEx Study: next step counseling and neutral assessment. AIDS Behav. 2012;16(5):1243–1259.
    1. Witzel TC, Nutland W, Bourne A. What qualities in a potential HIV pre-exposure prophylaxis service are valued by black men who have sex with men in London? A qualitative acceptability study. Int J STD AIDS. 2018;29(8):760–765.
    1. Galea JT, Kinsler JJ, Salazar X, et al. Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations. Int J STD AIDS. 2011;22(5):256–262.
    1. Jaiswal J, Griffin M, Singer SN, et al. Structural barriers to pre-exposure prophylaxis use among young sexual minority men: the P18 Cohort Study. Curr HIV Res. 2018;16(3):237–249.
    1. Philbin MM, Parker CM, Parker RG, et al. Gendered social institutions and preventive healthcare seeking for black men who have sex with men: the promise of biomedical HIV prevention. Arch Sex Behav. 2018;47(7):2091–2100.
    1. Raifman J, Nunn A, Oldenburg CE, et al. An evaluation of a clinical pre-exposure prophylaxis education intervention among men who have sex with men. Health Serv Res. 2018;53(4):2249–2267.
    1. Bourne A, Alba B, Garner A, et al. Use of, and likelihood of using, HIV pre-exposure prophylaxis among men who have sex with men in Europe and Central Asia: findings from a 2017 large geosocial networking application survey. Sex Transm Infect. 2019;95:187–192.
    1. Grov C, Kumar N. HIV pre-exposure prophylaxis (PrEP) is coming to Europe, but Are gay men ready to accept it? qualitative findings from Berlin Germany. Sex Res Soc Policy. 2018;15(3):283–289.
    1. Underhill K, Morrow KM, Colleran CM, et al. Access to healthcare, HIV/STI testing, and preferred pre-exposure prophylaxis providers among men who have sex with men and men who engage in street-based sex work in the US. PLoS ONE. 2014;9(11):e112425.
    1. Buttram ME. The informal use of antiretroviral medications for HIV prevention by men who have sex with men in South Florida: initiation, use practices, medications and motivations. Cult Health Sex. 2018;20(11):1185–1198.
    1. Vaccher SJ, Kaldor JM, Callander D, Zablotska IB, Haire BG. Qualitative insights into adherence to HIV pre-exposure prophylaxis (PrEP) among Australian gay and Bisexual men. AIDS Patient Care STDs. 2018;32(12):519–528.
    1. Karris MY, Beekmann SE, Mehta SR, Anderson CM, Polgreen PM. Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada. Clin Infect Dis. 2014;58(5):704–712.
    1. Daughtridge GW, Conyngham SC, Ramirez N, Koenig HC. I am men's health: generating adherence to HIV pre-exposure prophylaxis (PrEP) in young men of color who have sex with men. J Int Assoc Provid AIDS Care. 2015;14(2):103–107.
    1. Liu AY, Vittinghoff E, von Felten P, et al. Randomized controlled trial of a mobile health intervention to promote retention and adherence to pre-exposure prophylaxis among young people at risk for human immunodeficiency virus: the EPIC Study. Clin Infect Dis. 2018;68:2010–2017.
    1. Stekler JD, McMahan V, Ballinger L, et al. HIV pre-exposure prophylaxis prescribing through telehealth. J Acquir Immune Defic Syndr. 2018;77(5):e40–e42.
    1. Amico KR, Miller J, Balthazar C, et al. Integrated next step counseling (iNSC) for sexual health and PrEP use among young men who have sex with men: implementation and observations from ATN110/113. AIDS Behav. 2018;23:1812–1823.
    1. Rusie LK, Orengo C, Burrell D, et al. Preexposure prophylaxis initiation and retention in care over 5 years, 2012–2017: are quarterly visits too much? Clin Infect Dis. 2018;67(2):283–287.
    1. Smith DK, Toledo L, Smith DJ, Adams MA, Rothenberg R. Attitudes and program preferences of African-American Urban young adults about pre-exposure prophylaxis (PrEP) AIDS Educ Prev. 2012;24(5):408–421.
    1. Marcus JL, Hurley LB, Hare CB, et al. Preexposure prophylaxis for HIV prevention in a large integrated health care system: adherence, renal safety, and discontinuation. J Acquir Immune Defic Syndr. 2016;73(5):540–546.
    1. Mitchell JT, LeGrand S, Hightow-Weidman LB, et al. Smartphone-based contingency management intervention to improve pre-exposure prophylaxis adherence: pilot trial. JMIR Mhealth Uhealth. 2018;6(9):e10456.
    1. Dubov A, Fraenkel L, Yorick R, Ogunbajo A, Altice FL. Strategies to implement pre-exposure prophylaxis with men who have sex with men in Ukraine. AIDS Behav. 2018;22(4):1100–1112.
    1. Galindo GR, Walker JJ, Hazelton P, et al. Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation. Implement Sci. 2012;7(1):116–116.
    1. Bhatia R, Modali L, Lowther M, et al. Outcomes of preexposure prophylaxis referrals from public STI clinics and implications for the preexposure prophylaxis continuum. Sex Transm Dis. 2018;45(1):50–55.
    1. Hojilla, J. C. Optimizing the delivery of HIV pre-exposure prophylaxis (PrEP): An evaluation of risk compensation, disengagement, and the PrEP cascade (part 2). 2018b. . Accessed 7 Jan 2019.
    1. Kwakwa HA, Bessias S, Sturgis D, et al. Engaging United States black communities in HIV pre-exposure prophylaxis: analysis of a PrEP engagement cascade. J Natl Med Assoc. 2018;110(5):480–485.
    1. Spinelli MA, Scott HM, Vittinghoff E, et al. Provider adherence to pre-exposure prophylaxis monitoring guidelines in a large primary care network. Open Forum Infect Dis. 2018;5(6):1–4.
    1. Siegler AJ, Bratcher A, Weiss KM, et al. Location location location: an exploration of disparities in access to publicly listed pre-exposure prophylaxis clinics in the United States. Ann Epidemiol. 2018;28:858–864.
    1. Newman PA, Guta A, Lacombe-Duncan A, Tepjan S. Clinical exigencies, psychosocial realities: negotiating HIV pre-exposure prophylaxis beyond the cascade among gay, bisexual and other men who have sex with men in Canada. J Int AIDS Soc. 2018;21(11):e25211–e25211.
    1. Chan PA, Glynn TR, Oldenburg CE, et al. Implementation of preexposure prophylaxis for human immunodeficiency virus prevention among men who have sex with men at a New England Sexually transmitted diseases clinic. Sex Transm Dis. 2016;43(11):717–723.
    1. Arnold T, Brinkley-Rubinstein L, Chan PA, et al. Social, structural, behavioral and clinical factors influencing retention in Pre-Exposure Prophylaxis (PrEP) care in Mississippi. PLoS ONE. 2017;12(2):e0172354–e0172354.
    1. Hojilla, J. C. Optimizing the delivery of HIV pre-exposure prophylaxis (PrEP): An evaluation of risk compensation, disengagement, and the PrEP cascade (part 1). 2018a. . Accessed 7 Jan 2019
    1. Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDs. 2013;27(4):248–254.
    1. Kurtz SP, Buttram ME. Misunderstanding of pre-exposure prophylaxis use among men who have sex with men: public health and policy implications. LGBT Health. 2016;3(6):461–464.
    1. Merchant RC, Corner D, Garza E, et al. Preferences for HIV pre-exposure prophylaxis (PrEP) information among men-who-have-sex-with-men (MSM) at community outreach settings. J Gay Lesbian Ment Health. 2016;20(1):21–33.
    1. Shover CL, Javanbakht M, Shoptaw S, et al. HIV preexposure prophylaxis initiation at a large community clinic: differences between eligibility, awareness, and uptake. Am J Public Health. 2018;108(10):1408–1417.
    1. Marcus JL, Levine K, Grasso C, et al. HIV preexposure prophylaxis as a gateway to primary care. Am J Public Health. 2018;108(10):1418–1420.
    1. Rivierez I, Quatremere G, Spire B, Ghosn J, Rojas Castro D. Lessons learned from the experiences of informal PrEP users in France: results from the ANRS-PrEPage Study. AIDS Care. 2018;30:48–53.
    1. Refugio ON, Kimble MM, Silva CL, et al. PrEPTECH: a telehealth-based initiation program for human immunodeficiency virus pre-exposure prophylaxis in young men of color who have sex with men. A Pilot Study of feasibility. J Acquir Immune Defic Syndr. 2018;80:40.
    1. Ridgway JP, Almirol EA, Bender A, et al. Which patients in the emergency department should receive preexposure prophylaxis? Implementation of a predictive analytics approach. AIDS Patient Care STDs. 2018;32(5):202–207.
    1. Mutua G, Sanders E, Mugo P, et al. Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers. PLoS ONE. 2012;7(4):e33103–e33103.
    1. Sullivan PS, Driggers R, Stekler JD, et al. Usability and acceptability of a mobile comprehensive HIV prevention app for men who have sex with men: a Pilot Study. JMIR Mhealth Uhealth. 2017;5(3):e26–e26.
    1. Young I, Flowers P, McDaid LM. Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: findings from a qualitative study in Scotland. BMJ Open. 2014;4(11):e005717.
    1. Nodin N, Carballo-Dieguez A, Ventuneac AM, Balan IC, Remien R. Knowledge and acceptability of alternative HIV prevention bio-medical products among MSM who bareback. AIDS Care. 2008;20(1):106–115.
    1. Kojima N, Davey DJ, Klausner JD. Pre-exposure prophylaxis for HIV infection and new sexually transmitted infections among men who have sex with men. AIDS. 2016;30(14):2251–2252.
    1. Holt M, Murphy DA, Callander D, et al. Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men. Sex Transm Infect. 2012;88(4):258–263.
    1. Holt M, Lea T, Murphy D, et al. Willingness to use HIV pre-exposure prophylaxis has declined among australian gay and bisexual men: results from repeated national surveys, 2011–2013. J Acquir Immune Defic Syndr. 2014;67(2):222–226.
    1. Hoff CC, Chakravarty D, Bircher AE, et al. Attitudes towards PrEP and anticipated condom use among concordant HIV-negative and HIV-discordant male couples. AIDS Patient Care STDs. 2015;29(7):408–417.
    1. Eaton LA, Kalichman S. Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies. Curr HIV/AIDS Rep. 2007;4(4):165–172.
    1. Cassell MM, Halperin DT, Shelton JD, Stanton D. Risk compensation: the Achilles’ heel of innovations in HIV prevention? BMJ. 2006;332(7541):605–607.
    1. Bil JP, Davidovich U, van der Veldt WM, et al. What do Dutch MSM think of preexposure prophylaxis to prevent HIV-infection? A cross-sectional study. AIDS Behav. 2015;29(8):955–964.
    1. Eakle R, Venter F, Rees H. Pre-exposure prophylaxis (PrEP) in an era of stalled HIV prevention: Can it change the game? Retrovirology. 2018;15(1):29.
    1. Kippax S, Stephenson N. Beyond the distinction between biomedical and social dimensions of HIV prevention through the lens of a social public health. Am J Public Health. 2012;102:789–799.
    1. Marks SJ, Merchant RC, Clark MA, et al. Potential healthcare insurance and provider barriers to pre-exposure prophylaxis utilization among young men who have sex with men. AIDS Patient Care STDs. 2017;31(11):470–478.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe